These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34563788)

  • 21. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
    Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.
    Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF
    Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notch1 mutations are drivers of oral tumorigenesis.
    Izumchenko E; Sun K; Jones S; Brait M; Agrawal N; Koch W; McCord CL; Riley DR; Angiuoli SV; Velculescu VE; Jiang WW; Sidransky D
    Cancer Prev Res (Phila); 2015 Apr; 8(4):277-286. PubMed ID: 25406187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
    Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.
    Lapke N; Lu YJ; Liao CT; Lee LY; Lin CY; Wang HM; Ng SH; Chen SJ; Yen TC
    Oncotarget; 2016 Jul; 7(28):44194-44210. PubMed ID: 27283772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
    Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
    Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
    Xie S; Cai ZG; Shan XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
    Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
    Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
    Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
    Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
    Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
    Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M
    Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance in oral cavity squamous cell carcinoma of pathogenic somatic mitochondrial mutations.
    Lai CH; Huang SF; Liao CT; Chen IH; Wang HM; Hsieh LL
    PLoS One; 2013; 8(6):e65578. PubMed ID: 23799027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
    Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
    J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia.
    Farah CS; Shearston K; Melton PE; Fox SA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jul; 138(1):99-111. PubMed ID: 38760284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin.
    Zanaruddin SN; Yee PS; Hor SY; Kong YH; Ghani WM; Mustafa WM; Zain RB; Prime SS; Rahman ZA; Cheong SC
    PLoS One; 2013; 8(11):e80229. PubMed ID: 24224046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic landscape of esophageal squamous cell carcinoma.
    Gao YB; Chen ZL; Li JG; Hu XD; Shi XJ; Sun ZM; Zhang F; Zhao ZR; Li ZT; Liu ZY; Zhao YD; Sun J; Zhou CC; Yao R; Wang SY; Wang P; Sun N; Zhang BH; Dong JS; Yu Y; Luo M; Feng XL; Shi SS; Zhou F; Tan FW; Qiu B; Li N; Shao K; Zhang LJ; Zhang LJ; Xue Q; Gao SG; He J
    Nat Genet; 2014 Oct; 46(10):1097-102. PubMed ID: 25151357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance and actionable mutational spectrum in oral squamous cell carcinoma.
    Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K
    J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
    Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
    Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of somatic mutations in the D-loop of mitochondrial DNA on the survival of oral squamous cell carcinoma patients.
    Lin JC; Wang CC; Jiang RS; Wang WY; Liu SA
    PLoS One; 2015; 10(4):e0124322. PubMed ID: 25906372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.